Suchergebnisse - "Domchek, Susan M"

PubPharm (519)

31

Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients

enthalten in: The Journal of urology | 2023

von Breen, K. | Symecko, H. | Spielman, K. | +15

CommentIn: J Urol. 2023 May;209(5):926-927. - PMID 36974723

32

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

enthalten in: NPJ breast cancer | 2023

von Muranen, T. | Morra, A. | Khan, S. | +67

33

Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers

enthalten in: Journal of genetic counseling | 2023

von McKenna, D. | Sanchez, P. | Powers, J. | +12

34

Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian Cancer

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2023

von Lau-Min, K. | McCarthy, A. | Nathanson, K. | +1

CommentIn: J Natl Compr Canc Netw. 2023 Apr;21(4):430-432. - PMID 37015334

35

Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Yadav, S. | Boddicker, N. | Na, J. | +33

36

Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood

enthalten in: Clinical genetics | 2023

von Maxwell, K. | Patel, V. | Nead, K. | +11

37

Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer : final results from Study 10

enthalten in: British journal of cancer | 2023

von Kristeleit, R. | Drew, Y. | Oza, A. | +13

38

Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors : Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial

enthalten in: JAMA oncology | 2023

von Schram, A. | Colombo, N. | Arrowsmith, E. | +20

CommentIn: JAMA Oncol. 2023 Jan 1;9(1):25-27. - PMID 36394835

39

Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood

enthalten in: Clinical Genetics | 2023

von Maxwell, K. | Patel, V. | Nead, K. | +11

40

Olaparib efficacy in patients with germline BRCA‐mutated, HER2‐negative metastatic breast cancer : Subgroup analyses from the phase III OlympiAD trial

enthalten in: International Journal of Cancer | 2023

von Senkus, E. | Delaloge, S. | Domchek, S. | +8